scispace - formally typeset
R

Ren Zhang

Researcher at Guangzhou University of Chinese Medicine

Publications -  15
Citations -  231

Ren Zhang is an academic researcher from Guangzhou University of Chinese Medicine. The author has contributed to research in topics: Apoptosis & Caspase 3. The author has an hindex of 6, co-authored 13 publications receiving 128 citations. Previous affiliations of Ren Zhang include University of California, Davis.

Papers
More filters
Journal ArticleDOI

Protective effects of baicalin on LPS-induced injury in intestinal epithelial cells and intercellular tight junctions

TL;DR: Baicalin has the capacity to protect IEC-6 cells and the intercellular tight junctions from LPS-induced injury and the mechanisms may be associated with inhibiting the production of inflammatory cytokines, and up-regulating the mRNA and protein expression of ZO-1.
Journal ArticleDOI

Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3

TL;DR: Investigating the anti-HCC properties of dioscin in vitro and in vivo demonstrated that Dioscin inhibited proliferation of HCC cell lines in a dose-dependent manner, and displayed anticancer activity via up-regulating expression of TP53, BAX and CASP3 protein, as well as down- Regulating BCL2 in Bel-7402 cells.
Journal ArticleDOI

Baicalin Protects against TNF-α-Induced Injury by Down-Regulating miR-191a That Targets the Tight Junction Protein ZO-1 in IEC-6 Cells

TL;DR: Results indicate that baicalin exerts a protective effect on IEC-6 (rat small intestinal epithelial cells) cells against TNF-α-induced injury, which is at least partly via inhibiting the expression of miR-191a, thus increasing ZO-1 mRNA and protein levels.
Journal ArticleDOI

Berberine chloride suppresses non-small cell lung cancer by deregulating Sin3A/TOP2B pathway in vitro and in vivo

TL;DR: A new mechanism that BBC suppresses human NSCLC by deregulating Sin3A/TOP2B pathway, leading to DNA damage and apoptosis in human NSclC in vitro and in vivo is demonstrated.
Journal ArticleDOI

Demethyleneberberine induces cell cycle arrest and cellular senescence of NSCLC cells via c-Myc/HIF-1α pathway.

TL;DR: In this article, Demethyleneberberine (DMB) was used to suppress non-small cell lung cancer (NSCLC) cells in vitro and in vivo.